Meta-analysis of Relacorilant Plus Nab-paclitaxel Efficacy in Patients With Platinum-resistant Ovarian Cancer (PROC) Enrolled to ROSELLA and Study 552
Presented: European Society for Medical Oncology, 26 October 2026, Madrid, Spain
Presenter: Alexander B. Olawaiye, M.D.
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.
